Tax News Update    Email this document    Print this document  

September 27, 2023
2023-1610

IRS issues proposed regulations on reporting requirements for IRC Section 5000D excise tax on designated drugs

The IRS and Treasury Department issued proposed regulations (REG-115559-23) on how to report liability for the IRC Section 5000D excise tax imposed on manufacturers, producers or importers of certain designated (negotiation eligible) drugs sold during the applicable statutory period. Taxpayers would be required to report the IRC Section 5000D tax on Form 720, Quarterly Federal Excise Tax Return, in each quarter in which liability for the tax is incurred. Taxpayers would not be required to make semimonthly deposits of the IRC Section 5000D tax. The proposed rules would apply to calendar quarters beginning on or after October 1, 2023, and taxpayers can rely on them for returns beginning on this date.

Published by NTD's Tax Technical Knowledge Services group; Andrea Ben-Yosef, legal editor

 

The information contained herein is general in nature and is not intended, and should not be construed, as legal, accounting or tax advice or opinion provided by Ernst & Young LLP to the reader. The reader also is cautioned that this material may not be applicable to, or suitable for, the reader's specific circumstances or needs, and may require consideration of non-tax and other tax factors if any action is to be contemplated. The reader should contact his or her Ernst & Young LLP or other tax professional prior to taking any action based upon this information. Ernst & Young LLP assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein.

 

Copyright © 1996 – 2024, Ernst & Young LLP

 

All rights reserved. No part of this document may be reproduced, retransmitted or otherwise redistributed in any form or by any means, electronic or mechanical, including by photocopying, facsimile transmission, recording, rekeying, or using any information storage and retrieval system, without written permission from Ernst & Young LLP.

 

EY US Tax News Update Master Agreement | EY Privacy Statement